Have a feature idea you'd love to see implemented?
Let us know!
VMD Viemed Healthcare Inc
Price (delayed)
$8
Market cap
$311.49M
P/E Ratio
29.63
Dividend/share
N/A
EPS
$0.27
Enterprise value
$307.4M
Viemed Healthcare Inc. is a provider of in-home medical equipment and post-acute respiratory healthcare services in the United States. Viemed's service offerings are focused on effective in-home treatment with clinical
Highlights
The company's debt fell by 42% QoQ and by 30% YoY
The revenue has grown by 26% year-on-year and by 4.2% since the previous quarter
VMD's quick ratio is up by 8% year-on-year but it is down by 8% since the previous quarter
The price to earnings (P/E) is 8% higher than the 5-year quarterly average of 27.5
Key stats
What are the main financial stats of VMD
Market
Valuations
Earnings
Shares outstanding
38.94M
Market cap
$311.49M
Enterprise value
$307.4M
Price to earnings (P/E)
29.63
Price to book (P/B)
2.49
Price to sales (P/S)
1.45
EV/EBIT
19.47
EV/EBITDA
7.55
EV/Sales
1.43
Revenue
$214.3M
Gross profit
$129.18M
Net income
$10.43M
EBIT
$15.79M
EBITDA
$40.71M
Free cash flow
$11.41M
Per share
Balance sheet
Liquidity
EPS
$0.27
EPS diluted
$0.26
Free cash flow per share
$0.29
Book value per share
$3.22
Revenue per share
$5.51
TBVPS
$3.49
Total assets
$169.53M
Total liabilities
$42.73M
Debt
$7.26M
Equity
$124.96M
Working capital
$11.25M
Debt to equity
0.06
Current ratio
1.31
Quick ratio
1.05
Net debt/EBITDA
-0.1
Margins
Efficiency
Dividend
EBITDA margin
19%
Gross margin
60.3%
Net margin
4.9%
Operating margin
7.8%
Return on assets
6.5%
Return on equity
8.8%
Return on invested capital
16.4%
Return on capital employed
11.9%
Return on sales
7.4%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
VMD stock price
How has the Viemed Healthcare stock price performed over time
Intraday
1.01%
1 week
0%
1 month
-8.47%
1 year
3.09%
YTD
-0.25%
QTD
-0.25%
Financial performance
How have Viemed Healthcare's revenue and profit performed over time
Revenue
$214.3M
Gross profit
$129.18M
Operating income
$16.74M
Net income
$10.43M
Gross margin
60.3%
Net margin
4.9%
The operating income has grown by 33% YoY and by 9% from the previous quarter
The revenue has grown by 26% year-on-year and by 4.2% since the previous quarter
VMD's gross profit is up by 25% YoY and by 3% QoQ
The net income has increased by 13% year-on-year and by 10% since the previous quarter
Growth
What is Viemed Healthcare's growth rate over time
Valuation
What is Viemed Healthcare stock price valuation
P/E
29.63
P/B
2.49
P/S
1.45
EV/EBIT
19.47
EV/EBITDA
7.55
EV/Sales
1.43
Viemed Healthcare's EPS has increased by 13% YoY and by 8% QoQ
The price to earnings (P/E) is 8% higher than the 5-year quarterly average of 27.5
The P/B is 14% lower than the 5-year quarterly average of 2.9 and 4.2% lower than the last 4 quarters average of 2.6
The equity is up by 10% year-on-year and by 4.7% since the previous quarter
The P/S is 31% below the 5-year quarterly average of 2.1 and 3.3% below the last 4 quarters average of 1.5
The revenue has grown by 26% year-on-year and by 4.2% since the previous quarter
Efficiency
How efficient is Viemed Healthcare business performance
The company's return on invested capital rose by 10% YoY and by 6% QoQ
The ROA is up by 8% QoQ and by 3.2% YoY
The ROE has grown by 7% from the previous quarter and by 4.8% YoY
Viemed Healthcare's return on sales has increased by 4.2% QoQ but it has decreased by 3.9% YoY
Dividends
What is VMD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for VMD.
Financial health
How did Viemed Healthcare financials performed over time
VMD's current ratio is up by 10% YoY but it is down by 8% from the previous quarter
Viemed Healthcare's total assets has increased by 9% YoY and by 3.4% from the previous quarter
The company's debt is 94% lower than its equity
The company's debt fell by 42% QoQ and by 30% YoY
Viemed Healthcare's debt to equity has decreased by 40% QoQ and by 33% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.